...
机译:球形人肝脏微观鉴定临床药物诱导肝损伤的效用
Genentech Inc Dept Safety Assessment Invest Toxicol 1 DNA Way San Francisco CA 94080 USA;
AstraZeneca Drug Safety &
Metab Alderley Pk Macclesfield SK10 4TG Cheshire England;
Genentech Inc Dept Safety Assessment Invest Toxicol 1 DNA Way San Francisco CA 94080 USA;
AstraZeneca Drug Safety &
Metab Alderley Pk Macclesfield SK10 4TG Cheshire England;
AstraZeneca Discovery Sci Alderley Pk Macclesfield SK10 4TG Cheshire England;
AstraZeneca Discovery Sci Alderley Pk Macclesfield SK10 4TG Cheshire England;
Genentech Inc Nonclin Biostat Prod Dev 1 DNA Way San Francisco CA 94080 USA;
InSphero AG Wagistr 27 CH-8952 Schlieren Switzerland;
InSphero AG Wagistr 27 CH-8952 Schlieren Switzerland;
InSphero AG Wagistr 27 CH-8952 Schlieren Switzerland;
AstraZeneca Drug Safety &
Metab Alderley Pk Macclesfield SK10 4TG Cheshire England;
InSphero AG Wagistr 27 CH-8952 Schlieren Switzerland;
AstraZeneca Drug Safety &
Metab Alderley Pk Macclesfield SK10 4TG Cheshire England;
DILI; Spheroid culture; Microtissue; Hepatocyte; Hepatotoxicity; Drug discovery;
机译:球形人肝脏微观鉴定临床药物诱导肝损伤的效用
机译:人肝微粒体培养的HepG2细胞中药物诱发的肝损伤的预测
机译:临床药物诱发的肝损伤的细胞成像预测。
机译:基于图谱神经网络的转录反应数据的药物诱导的肝损伤预测模型
机译:Th17途径参与药物不良反应:药物诱发的自身免疫和药物诱发的肝损伤的机制研究。
机译:球形人肝脏微组织在预测临床药物性肝损伤中的作用
机译:球形人肝显微组织在预测临床药物诱发的肝损伤中的效用。